AML	acute myeloid leukemia
AR	androgen receptor
CAR	chimeric antigen receptor
EC50	half-maximal effective concentration
ELISA	enzyme-linked immunosorbent assays
E:T	effector-to-target
His	6x histidine
mAb	monoclonal antibody
mCRPC	metastatic castration-resistant prostate cancer
mPCa	metastatic prostate cancer
MFI	median fluorescence intensity
PARP	poly(ADP-ribose) polymerase
PBMC	peripheral mononuclear cells
PCa	prostate cancer
PET	positron emission tomography
PSCA	prostate stem cell antigen
PSMA	prostate-specific membrane antigen
RevCAR	reverse chimeric antigen receptor
RevTM	reverse target module
VH	variable domain of the heavy chain
VL	variable domain of the light chain